GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Spectral AI MDAI · USD

Health Care · US listing · 🇺🇸 United States

Compare

1.53

+2.68%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Spectral AI

From its filings with the US Securities and Exchange Commission

SEC filings

Spectral AI is based in Dallas, Texas and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker MDAI. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2025, it reported revenue of $19.6m and a net loss of $7.6m. At that date it held total assets of $21.4m and shareholders' equity of −$5.7m.

Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
12 Feb 2021
Head office
2515 MCKINNEY AVE #1000, DALLAS, TX, 75201
Incorporated in
DE
Classification
Surgical & Medical Instruments & Apparatus
Filer status
<br>Emerging growth company

Leadership

Pay as last reported

  • Dr. J. Michael DimaioChairman of the Board$95,850
  • Mr. Vincent CaponeChief Financial Officer, General Counsel, Corporate Secretary$987,471
  • Mr. Stan MicekChief Operating Officer$270,000
  • Mr. Louis PercocoGeneral Manager$430,880
  • Mr. Jeremiah SparksChief Commercial Officer$325,257
  • Dr. Jeffrey ThatcherChief Scientist$448,626
  • Mr. Richard CottonLead Independent Director$154,781
  • Mr. Erich SpangenbergDirector$83,400
  • Mr. Martin MellishIndependent Director$131,800
  • Mr. Deepak SadagopanIndependent Director$113,400
  • Ms. Marion SnyderIndependent Director$60,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Spectral AI Inc operates in the Health Care Equipment & Supplies industry sector.
  • The DeepView platform provides objective assessment of wound healing potential before treatment.
  • Proprietary optical technology integrates with AI algorithms to see below the skin surface.

Weaknesses

  • The company is headquartered in Dallas, Texas, which may limit local talent access.
  • The firm went public on 12 February 2021, indicating a relatively short public history.
  • Future clinical applications are mentioned but not yet fully developed or deployed.

Opportunities

  • Diabetic foot ulcers represent a significant market segment for the DeepView diagnostic device.
  • Burn wound care offers a specialized niche for accurate treatment decisions using AI.
  • Medical diagnostics for accurate treatment decisions can expand into other clinical applications.

Threats

  • Competition in the Health Care Equipment & Supplies industry may intensify rapidly.
  • Regulatory changes in the US could impact the approval of medical diagnostic devices.
  • Adoption of AI-enabled algorithms in wound care depends on clinician acceptance rates.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.